In today’s episode, I interview Molly Broache, a women’s health nurse practitioner and currently the Associate Director of Medical Affairs in the US Region for BD Integrated Diagnostic Solutions. BD is one of the largest global medical technology companies in the world with 75,000 employees in virtually every country. The BD Onclarity™ HPV Assay is the only FDA-approved HPV assay that identifies six high-risk HPV genotypes individually, including HPV 31. As more women received the HPV vaccine, the prevalence of two of the three highest-risk genotypes – HPV 16 and 18 – have declined. Unfortunately, HPV 31 remains prevalent. BD’s diagnostic tools provide a new standard of care for women. Learn more about BD’s commitment to women’s health at https://Womens-health-solutions.bd.com Enjoy the episode!